These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3502804)

  • 1. Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test.
    Schweitzer I; Maguire KP; Gee AH; Tiller JW; Biddle N; Davies B
    Br J Psychiatry; 1987 Dec; 151():780-4. PubMed ID: 3502804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in agoraphobia.
    Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
    J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What does the dexamethasone suppression test identify?
    Krishnan KR; France RD; Pelton S; McCann UD; Manepalli AN; Davidson JR
    Biol Psychiatry; 1985 Sep; 20(9):957-64. PubMed ID: 4027315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In unipolar depression does the response to the dexamethasone suppression test predict a symptomatic recurrence after clinical cure?].
    Charles G; Schittecatte M; Maes JM; Rush AJ; Wilmotte J
    Acta Psychiatr Belg; 1986; 86(3):249-56. PubMed ID: 3751648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of weight change on the dexamethasone suppression test in depressed and anorexic patients.
    Schweitzer I; Maguire KP; Tiller JW; Gee AH; Harrison LC; Davies BM
    Br J Psychiatry; 1986 Dec; 149():751-5. PubMed ID: 3790873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW; Wilens TE; Baldessarini RJ
    Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
    Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age effects in serial hypothalamic-pituitary-adrenal monitoring.
    Greden JF; Flegel P; Haskett R; Dilsaver S; Carroll BJ; Grunhaus L; Genero N
    Psychoneuroendocrinology; 1986; 11(2):195-204. PubMed ID: 3749402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
    Gerken A; Maier W; Holsboer F
    Psychoneuroendocrinology; 1985; 10(3):261-71. PubMed ID: 4059474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression].
    Cubała WJ; Landowski J
    Psychiatr Pol; 2006; 40(3):415-30. PubMed ID: 17037809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
    Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test in repeated hospitalizations.
    Grunhaus L; Greden JF; Carroll BJ; Shein H
    Biol Psychiatry; 1983 Dec; 18(12):1497-502. PubMed ID: 6661477
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal-axis hyperactivity in bulimia.
    Hudson JI; Pope HG; Jonas JM; Laffer PS; Hudson MS; Melby JC
    Psychiatry Res; 1983 Feb; 8(2):111-7. PubMed ID: 6574529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN; Sharma RP; Janicak PG; Davis JM
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.